View Author
scopus: 7006798084

Etzioni, R.

(Ruth Etzioni)


cancer model screening prostate prostate cancer disease incidence diagnosis psa screening estimate overdiagnosi population treatment result study stage miscan detection absence onset history death gleason psa detection fhcrc level progression grade score cancer institute state umich prostate cancer death article european randomized study survival tumor parameter seer 9 incidence overdiagnosed trend event sensitivity psa-detected biopsy finition 2–7 group progression events fhcrc model erspc mortality non-overdiagnosed 50–84 years disease onset distribution trial psa level miscan model overdiagnosed cancers end results program project psa-detected prostate cancer rotterdam etzioni projection biomarker modeling epidemiology 8–10 umich model lifetime figure gleason score 2–7 core catchment areas research overdiagnosis estimates antigen 3 models disease progression




2 Most Recent Publications

What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models (Article)
Gulati, R. Wever, E.M. Etzioni, R. Tsodikov, A. Penson, D.F. Inoue, L.Y.T. Katcher, J. Lee, S.Y. Heijnsdijk, E.A.M. Draisma, G. Koning, H.J. de
2011-05-01
Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context (Article)
Draisma, G. Etzioni, R. Tsodikov, A. Mariotto, A. Wever, E.M. Gulati, R. Feuer, E. Koning, H.J. de
2009-03-01